Completed PHASE4 INTERVENTIONAL NCT00199095

Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia

Pilot Study for Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia

Sponsor: Goethe University

Conditions Adult Acute Lymphocytic Leukemia

Interventions Adriamycin Cyclophosphamide Cytarabine Dexamethasone Idarubicin Ifosfamide Mercaptopurine Methotrexate VM26 Vincristine

Updated 7 times since 2017 Last updated: Mar 16, 2023 Started: Feb 28, 1997 Primary completion: Jun 30, 2003 Completion: Jun 30, 2003

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Adult Acute Lymphocytic Leukemia and is currently completed. Goethe University leads this study, which shows 7 recorded versions since 1997 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE4
Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Apr 2023 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Apr 2023 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Feb 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Goethe University

Data source: Goethe University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Frankfurt, Germany